SilverArc reports 176,057 shares (4.94%) in NextCure

NextCure, Inc. reporting persons SilverArc Capital Management, LLC and Devesh Gandhi each disclose beneficial ownership of 176,057 shares of Class A Common Stock, representing 4.94% of the class.

Rhea-AI Filing Summary

NextCure, Inc. reporting persons SilverArc Capital Management, LLC and Devesh Gandhi each disclose beneficial ownership of 176,057 shares of Class A Common Stock, representing 4.94% of the class. The filing shows shared voting and shared dispositive power over those shares. The filing is signed on 05/13/2026.

Insights

Institutional Ownership Analyst

Small institutional stake reported with shared control.

SilverArc Capital Management, LLC and Devesh Gandhi are disclosed as the reporting persons holding 176,057 shares, equal to 4.94% of Class A Common Stock as reported. The position is described with shared voting and shared dispositive power, indicating control routed through the reporting structure rather than sole authority.

Timing and cash-flow treatment are not stated beyond the signatures dated 05/13/2026. Subsequent filings would show any changes in percentage or conversion of shared authority into sole control.

Key Figures

Beneficial ownership: 176,057 shares Percent of class: 4.94% CUSIP: 65343E207 +1 more

4 metrics

Beneficial ownership 176,057 shares Class A Common Stock

Percent of class 4.94% Class A Common Stock

CUSIP 65343E207 Class A Common Stock identifier

Signature date 05/13/2026 Filing signature date

Key Terms

Schedule 13G/A, Beneficial ownership, Shared dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 1 ) NextCure, INC. Class A Common Stock"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership regulatory

"Item 4. | Ownership (a) | Amount beneficially owned: 176057"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

Shared dispositive power regulatory

"Shared Dispositive Power 176,057.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does SilverArc Capital report in NextCure (NXTC)?

SilverArc reports beneficial ownership of 176,057 shares, equal to 4.94% of NextCure Class A Common Stock. The filing lists shared voting and shared dispositive power over those shares and is signed on 05/13/2026.

Who is listed as the reporting person alongside SilverArc in the NXTC filing?

Devesh Gandhi is listed alongside SilverArc Capital Management, LLC as a reporting person. Both are shown with shared voting and shared dispositive power over 176,057 shares in the filing signed 05/13/2026.

What class of NextCure stock and CUSIP are referenced in the Schedule 13G/A?

The filing pertains to Class A Common Stock with CUSIP 65343E207. The reported beneficial ownership is 176,057 shares, representing 4.94% of that class.

Does the Schedule 13G/A show sole voting or disposal power for the holders?

No. The filing shows 0 shares of sole voting power and sole dispositive power; it records 176,057 shares of shared voting power and shared dispositive power instead.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:42 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

NextCure, INC.

(Name of Issuer)

Class A Common Stock

(Title of Class of Securities)

65343E207

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 65343E207

1

Names of Reporting Persons

SilverArc Capital Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 176,057.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 176,057.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

176,057.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

CUSIP Number(s): 65343E207

1

Names of Reporting Persons

Devesh Gandhi

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 176,057.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 176,057.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

176,057.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.9 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: NextCure, INC.
(b)	Address of issuer's principal executive offices: 9000 Virginia Manor Road, Suite 200, Beltsville, MD 20705
Item 2.
(a)	Name of person filing: SilverArc Capital Management, LLC ("SilverArc") and Devesh Gandhi ("Gandhi" and together with SilverArc, the "Reporting Persons")
(b)	Address or principal business office or, if none, residence: 20 Park Plaza, Suite 620 Boston, MA 02116.
(c)	Citizenship: SilverArc is a Delaware limited liability company. Gandhi is a citizen of the United States.
(d)	Title of class of securities: Class A Common Stock
(e)	CUSIP No.: 65343E207
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 176057
(b)	Percent of class: 4.94 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 176057
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 176057
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

SilverArc Capital Management, LLC

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	05/13/2026

Devesh Gandhi

Signature:	Devesh S. Gandhi
Name/Title:	Sole Member of SilverArc Capital Management, LLC
Date:	05/13/2026